FindTrial
Sign In

Whether hybrid training during dialysis improve patient's physical function and inflammation and arteriosclerosis

Whether hybrid training during dialysis improve patient's physical function and inflammation and arteriosclerosis - Carnitine deficiency is associated with decreased exercise activity in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033833
Enrollment
40
Registered
2018-08-29
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodyalysis people

Interventions

We administer to the patient levocarnitine 1000 mg/dose during every dialysis for 3 months and compare with the placebo group. We administer to the patient levocarnitine 1000 mg/dose during every dial

Sponsors

Division of Nephrology, Department on Medicine, Kurume University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients over the age of 20 years with end stage renal disease undergoing hemodialysis 2.Patients able to provide written informed consent for study participation

Exclusion criteria

Exclusion criteria: 1.Patients under the age of 20 years old 2.Patients who are contraindicated in the package insert of Levocarnitine 3.Patients undergoing combination therapy with peritoneal dialysis and hemodialysis 4.Pregnant woman, or a woman who have possibility of pregnancy 5.Others not inadequate judged by a physician 6.Patients who do not obtain consent

Design outcomes

Primary

MeasureTime frame
Exercise tolerance test—

Secondary

MeasureTime frame
Before exercise and after 3 months Grip strength time up Go test Lower limb muscle strength functional reach test Body composition measurement Thigh muscle area by MRI etc—

Countries

Japan

Contacts

Public ContactJunko Yano

Kurume University Division of Nephrology, Department on Medicine

yano_junko@med.kurume-u.ac.jp0942-31-7002

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026